Cogentix Medical (NASDAQ: CGNT) reported Q2 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $13.9 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.